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Phase of Illness in palliative care:  
Cross-sectional analysis of clinical  
data from community, hospital  
and hospice patients
Harriet Mather1,2, Ping Guo2, Alice Firth2, Joanna M Davies2,  
Nigel Sykes3, Alison Landon3 and Fliss EM Murtagh4
Abstract
Background: Phase of Illness describes stages of advanced illness according to care needs of the individual, family and suitability of 
care plan. There is limited evidence on its association with other measures of symptoms, and health-related needs, in palliative care.
Aims: The aims of the study are as follows. (1) Describe function, pain, other physical problems, psycho-spiritual problems and family 
and carer support needs by Phase of Illness. (2) Consider strength of associations between these measures and Phase of Illness.
Design and setting: Secondary analysis of patient-level data; a total of 1317 patients in three settings. Function measured using 
Australia-modified Karnofsky Performance Scale. Pain, other physical problems, psycho-spiritual problems and family and carer 
support needs measured using items on Palliative Care Problem Severity Scale.
Results: Australia-modified Karnofsky Performance Scale and Palliative Care Problem Severity Scale items varied significantly by 
Phase of Illness. Mean function was highest in stable phase (65.9, 95% confidence interval = 63.4–68.3) and lowest in dying phase 
(16.6, 95% confidence interval = 15.3–17.8). Mean pain was highest in unstable phase (1.43, 95% confidence interval = 1.36–1.51). 
Multinomial regression: psycho-spiritual problems were not associated with Phase of Illness (χ2 = 2.940, df = 3, p = 0.401). Family and 
carer support needs were greater in deteriorating phase than unstable phase (odds ratio (deteriorating vs unstable) = 1.23, 95% 
confidence interval = 1.01–1.49). Forty-nine percent of the variance in Phase of Illness is explained by Australia-modified Karnofsky 
Performance Scale and Palliative Care Problem Severity Scale.
Conclusion: Phase of Illness has value as a clinical measure of overall palliative need, capturing additional information beyond 
Australia-modified Karnofsky Performance Scale and Palliative Care Problem Severity Scale. Lack of significant association between 
psycho-spiritual problems and Phase of Illness warrants further investigation.
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Original Article
What is already known about the topic?
•• Phase of Illness, used for casemix classification for palliative care in Australia and now the United Kingdom, predicts 
resource use and has fair inter-rater reliability.
•• Its relationship to validated measures of clinical need has not been demonstrated.
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Introduction
‘Phase of Illness’ is used in advanced illness to describe 
the distinct stages of an individual’s illness according to 
the care needs of the individual, the family and the suita-
bility of the current care plan to address these needs.1 It 
was originally derived from work on casemix classifica-
tion within palliative care in Australia and is a major deter-
minant of resource use.2
Patients are classified into one of five phases, outlined 
in Table 1, with a new phase assigned whenever a clinical 
change requires patient and family re-assessment and 
modification of the existing care plan. Phase of Illness is 
(except for the dying and deceased phases) not reliant on 
stage of disease and prognosis, and patients may move 
between phases in any sequence.3 Distinct characteristics 
of Phase of Illness are (1) its relationship with needs and 
resource use and (2) the individual and family as the unit 
of care. The term ‘episode of care’ is used to define the 
period of contact between a patient and a provider or team 
of providers that occurs in one setting, beginning with the 
first contact with the patient and ending at discharge or 
when the patient dies. One episode of care may comprise 
one, or multiple phases; mean number of phases per epi-
sode has been reported as 1.68 for inpatient care and 1.31 
for community care.4
Phase of Illness was originally developed, through clin-
ical consensus, as a key component of a casemix classifi-
cation for palliative care.4 Casemix classifications 
categorise patients into homogeneous groups of need and 
resource use on the basis of key predictor variables and, in 
addition to underpinning reimbursement systems within 
healthcare, provide a means of capturing and communicat-
ing patient care needs. In other areas of healthcare, espe-
cially within acute hospital-based specialties such as 
surgery and orthopaedics, diagnosis and interventions 
often form the basis of casemix classifications, as in the 
healthcare resource group system in England.5 However, 
in palliative care, diagnosis is a poor predictor of need and 
resource use, a challenge common to some other areas of 
healthcare where improvements in quality of life and func-
tion are the goals of care (such as psychiatry, psycho-geri-
atrics and rehabilitation medicine).6 Phase of Illness was 
thus developed in response to this challenge, as the key 
clinical variable within a casemix classification for pallia-
tive care in Australia.7 The original definitions of the dif-
ferent phases have been reviewed in recent years with little 
clinical call for change.1 Phase of Illness remains the basis 
of the most recent iteration of a casemix classification for 
palliative care in Australia and has recently been intro-
duced in England in this capacity.8,9
It is important to know how Phase of Illness behaves 
alongside other validated measures of symptoms and 
needs in palliative care. A recent study across 10 palliative 
care services in Australia reported fair inter-rater reliabil-
ity and acceptability.1 But there remains little published 
evidence on the association of Phase of Illness with other 
validated measures of clinical needs. In order to address 
this knowledge-gap, this study aims to
1. Describe the distribution of (a) function, (b) pain, 
(c) other physical problems, (d) psycho-spiritual 
problems and (e) family and carer support needs, 
by Phase of Illness;
2. Examine, using multinomial logistic regression, 
associations between these five domains and Phase 
of Illness.
Methods
Setting and participants
A secondary analysis was undertaken of individual patient-
level data collected as part of routine clinical care between 
What this paper adds?
•• The different phases of illness are characterised by differences in function, pain, other physical problems, psycho-spiritual 
problems and family and carer support needs.
•• Pain is worst in the unstable phase, family and carer support needs are greatest in the deteriorating phase and function 
is worst in the dying phase.
•• Phase of Illness has been used as a measure to reflect changing care needs and captures additional clinical information 
beyond the combination of Australia-modified Karnofsky Performance Scale (AKPS) and Palliative Care Problem Severity 
Scale (PCPSS).
Implications for practice, theory or policy
•• Phase of Illness can be used to inform clinical interventions, casemix-adjust quality measures and potentially to underpin 
value-based reimbursement mechanisms in palliative care.
•• Palliative care teams should be trained in using Phase of Illness and be incentivized to record it routinely across all 
settings.
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March 2012 and December 2013 from patients attending 
three palliative care services within the South East of 
England. These data were collected as part of a pilot data 
collection following recommendations by the independent 
Palliative Care Funding Review in England.10 The hospital 
support service (‘hospital’) provides a specialist consulta-
tive and advisory palliative care service within one hospi-
tal site with approximately 1000 beds. The inpatient 
palliative care unit (‘hospice’) provides on-site, 24-h, 
multi-disciplinary specialist palliative care to individuals 
with life-limiting illness within a 48-bed facility. The com-
munity palliative care service (‘community’) provides spe-
cialist palliative care services to individuals within their 
primary place of residence, including advice and support 
to general palliative care providers in the community. All 
adult patients attending the services over the time period of 
data collection were eligible for inclusion in this analysis.
Data collection
For each participant, any member of the specialist pallia-
tive care team (i.e. doctors, registered nurses, nurse practi-
tioners or social workers) with knowledge of the 
individual’s clinical status made an assessment of Phase of 
Illness, along with function, pain, other physical problems, 
psycho-spiritual problems and family and carer support 
needs, at entry into the service and at each subsequent 
change in Phase of Illness (determined by the palliative 
care team member as defined above). Function was meas-
ured on an 11-point scale, the Australia-modified 
Karnofsky Performance Scale (AKPS), anchored between 
0 (deceased) and 100 (best possible function), demon-
strated to have good face and construct validity.11 Pain, 
other physical problems, psycho-spiritual problems and 
family and carer support needs were all measured using 
items within the Palliative Care Problem Severity Scale 
(PCPSS), rated as 0 (absent), 1 (mild), 2 (moderate) and 3 
(severe). These items have been demonstrated to have 
good inter-rater reliability for the measurement of these 
domains.12 Clinical and demographic data were extracted 
from the clinical record. Trained administrators entered 
data into Microsoft Excel, which was then imported into 
SPSS version 22. The data were anonymised at point of 
extraction.
Statistical analysis
All analyses were undertaken using SPSS version 22. 
Analysis was restricted to the first phase within an episode 
of care. Where an individual had more than one episode of 
care, the first episode of care within the time period of 
analysis was used. This approach was adopted to satisfy 
the assumption of independence of observations necessary 
for the analyses.
Table 1. Definitions of Phase of Illness, for use in palliative care/advanced illness.1
Phase of 
Illness
Patient in this phase when Phase ends when
Stable Patient’s problems and symptoms are adequately 
controlled by the established plan of care and further 
interventions to maintain symptom control and quality 
of life have been planned and family/carer situation is 
relatively stable and no new issues are apparent.
The needs of the patient and/or family/carer increase, 
requiring changes to the existing plan of care.
Unstable An urgent change in the plan of care or emergency 
treatment is required because the patient experiences 
a new problem that was not anticipated in the existing 
plan of care and/or the patient experiences a rapid 
increase in the severity of a current problem and/or 
family/carer circumstances change suddenly impacting 
patient care.
The new plan of care is in place, it has been reviewed 
and no further changes to the care plan are required. 
This does not necessarily mean that the symptom/
crises has fully resolved but there is a clear diagnosis 
and plan of care (i.e. patient is stable or deteriorating) 
and/or death is likely within days (i.e. patient is now 
dying).
Deteriorating The care plan addresses anticipated needs, but 
requires periodic review, because the patient’s overall 
functional status declines and the patient experiences 
a gradual worsening of existing problem(s) and/or the 
patient experiences a new, but anticipated, problem 
and/or the family/carer experiences gradual worsening 
distress that impacts the patient care.
Patient condition plateaus (i.e. patient is now stable) 
or an urgent change in the care plan or emergency 
treatment and/or family/carers experience a sudden 
change in their situation that impacts patient care, 
and urgent intervention is required (i.e. patient is now 
unstable) or death is likely within days (i.e. patient is 
now dying).
Dying Dying: death is likely within days. Patient dies or patient condition changes and death is 
no longer likely within days (i.e. patient is now stable 
and/or deteriorating).
Deceased The patient has died; bereavement support provided 
to family/carers is documented in the deceased 
patient’s clinical record.
Case is closed.
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Sample characteristics were described using mean and 
standard deviation (SD) for continuous variables, and fre-
quencies and percentages for categorical variables. 
Function, pain, other physical problems, psycho-spiritual 
problems and family and carer support needs were treated 
as continuous variables, and described using the mean and 
95% confidence intervals (CIs). Phase of Illness was treated 
as a categorical variable. Comparison of AKPS and items 
on the PCPSS across Phase of Illness was undertaken using 
one-way analysis of variance (ANOVA) where assump-
tions were met (or Welch’s ANOVA in the case of failure to 
meet the assumption of homogeneity of variance). Post hoc 
pairwise comparisons were undertaken using Tukey’s hon-
est significant difference (HSD) test or Games Howell test 
as appropriate, accounting for multiple testing. A multino-
mial regression was then undertaken with Phase of Illness 
as the dependent variable. AKPS and items on PCPSS sig-
nificantly associated with Phase of Illness in the univariate 
analysis were entered into the model in one block as main 
effects. We hypothesised that symptom burden would be 
highest in the unstable phase. We therefore chose to present 
the analysis using the unstable phase as the reference cate-
gory, to enable assessment of differences between this cat-
egory and the other categories of Phase of Illness.
Ethical approval
The study used data that were fully anonymised and there-
fore did not require approval from a research ethics com-
mittee in line with King’s College London’s Research 
Ethics Committee procedures. The protocol for data 
extraction and analysis was approved by Caldicott 
Guardians within the participating organisations before 
commencement of the project.
Results
Sample characteristics
The initial sample comprised 1317 individuals, who expe-
rienced 2354 phases of illness, within 1578 episodes of 
care. The first phase within the first episode of care for 
each of these 1317 individuals was used for the analysis; 
this consisted of 241 stable phases, 618 unstable phases, 
336 deteriorating phases and 122 dying phases. Table 2 
outlines the sample characteristics. The mean age of the 
sample was 72.9 (SD ± 14.1 years). Fifty-one percent were 
female. Seventy-one percent were based in the commu-
nity, 15.2% in the hospice and 13.7% in the hospital at the 
time of assessment. Seventy-five percent of the sample 
had a primary diagnosis of cancer.
Level of palliative care need by Phase of Illness
Function, pain, other physical problems, psycho-spiritual 
problems and family and carer support needs varied 
significantly by Phase of Illness, as reported in Table 3 and 
depicted in Figure 1. Function was highest in the stable 
phase, lowest in the dying phase and higher in the unstable 
phase than the deteriorating phase; the difference in func-
tion was significant across all pairwise comparisons (at 
p < 0.05). Pain, other physical problems and psycho-spir-
itual problems were all significantly higher in the unstable 
and deteriorating phases than the stable and dying phases 
(at p < 0.05), with higher pain additionally discriminating 
the unstable from the deteriorating phase (p < 0.05). 
Family and carer support needs did not differ significantly 
between the unstable, deteriorating and dying phases, but 
in all three phases were significantly higher than in the sta-
ble phase (at p < 0.05).
Multinomial logistic regression
According to the procedure outlined in the ‘Methods’ sec-
tion, a multinomial logistic regression model was fitted to 
the data, with ‘Phase of Illness’ as the dependent variable, 
and AKPS and the four PCPSS items entered as independ-
ent variables (Table 4). A model containing all five variables 
provided a good overall fit to the data (Pearson’s 
χ2 = 1516.796, df = 1779, p = 1.000) and was significantly 
Table 2. Clinical and baseline characteristics (n = 1317).
Characteristics  
Age, mean ± SD, years 72.9 ± 14.1
Gender, n (%)
 Male 664 (49.5)
 Female 652 (50.5)
 Missing 1 (0.0)
Care setting, n (%)
 Home 936 (71.1)
 Hospice 200 (15.2)
 Hospital 181 (13.7)
Diagnosis, n (%)
Cancer
 Gastrointestinal (including pancreas) 267 (20.2)
 Lung 202 (15.3)
 Genitourinary 189 (14.4)
 Breast 91 (6.9)
 Haematological 68 (5.2)
 Brain 41 (3.1)
 Head and neck 25 (1.9)
 Other cancer 109 (8.3)
Non-cancer
 Chronic obstructive pulmonary disease 52 (3.9)
 Dementia 45 (3.4)
 Neurological 41 (3.1)
 Cardiac failure 41 (3.0)
 Chronic renal failure 26 (2.0)
 Liver failure 8 (0.6)
 Other non-cancer conditions 113 (8.7)
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better than a constant-only model (χ2 = 741.034, df = 15, 
p < 0.005). Function (χ2 = 478.999, df = 3, p < 0.005), pain 
(χ2 = 47.521, df = 3, p < 0.005), other physical problems 
(χ2 = 24.369, df = 3, p < 0.005) and family and carer support 
needs (χ2 = 21.435, df = 3, p < 0.005) all made a significant 
contribution to the model, with function most strongly asso-
ciated with Phase of Illness. Only the psycho-spiritual prob-
lem score, after controlling for all other variables in the 
model, was not associated with Phase of Illness (χ2 = 2.940, 
df = 3, p = 0.401). Forty-nine percent of the variance in Phase 
of Illness was explained by measures of function, pain, other 
physical problems and family and carer support needs 
(Nagelkerke’s pseudo R2 = 0.488).
Table 4 reports the odds ratios (ORs) for the association 
of AKPS and the four PCPSS items with Phase of Illness, 
with unstable phase as the reference category. The results 
are consistent with the univariate analysis, although with 
some exceptions. In the multivariate analysis, other physi-
cal problems were higher in the dying phase than both the 
deteriorating phase and the unstable phase, and the differ-
ences between these three phases did not reach statistical 
significance in this additional analysis. Family and carer 
support needs, in addition to being lower in the stable 
phase as compared to all other phases, consistent with the 
univariate analysis, were also significantly higher in the 
deteriorating phase than the unstable phase (OR (deterio-
rating vs unstable) = 1.23 (95% CI = 1.01−1.49)). In addi-
tional analyses, the difference in family and carer support 
needs between the deteriorating and unstable phases 
reached significance after adjustment for pain alone, sig-
nificantly higher in the unstable phase, (OR (deteriorating 
vs unstable) = 1.25 (1.06–1.48), p = 0.007) and retained 
significance after adjusting for function, significantly 
lower in the deteriorating phase (OR (deteriorating vs 
unstable) = 1.20 (1.01–1.42), p = 0.034).
Discussion
Main findings
In this study, we have described the significant differences 
in palliative care needs (as represented by measures of func-
tion, pain, other physical problems, psycho-spiritual prob-
lems and family and carer support needs) according to Phase 
of Illness. The variance in Phase of Illness was not accounted 
for entirely by AKPS and the selected items on the PCPSS; 
however, demonstrating that Phase of Illness captures more 
than the combination of these measures. These findings 
underpin the value of Phase of Illness in clinical practice as 
a measure of overall clinical need, and potentially as a deter-
minant of resource use to meet those needs.
Considering the characteristics of the individual phases, 
these were consistent with the definitions outlined in 
Table 1. Thus, the stable phase was differentiated from all 
other phases by higher function, lower other physical 
problems and lesser family and carer support needs. 
Furthermore, a lower pain level distinguished the stable 
phase from all except the dying phase. The unstable phase 
Table 3. Mean level of function, pain, other physical problems, family and carer support needs and psycho-spiritual problems by 
Phase of Illness.
Functiona 
(n = 1305)
Painb  
(n = 1261)
Other physical 
problemsc (n = 1260)
Psycho-spiritual 
problemsd (n = 1259)
Family and carer support 
needse (n = 1259)
 Possible range: 0 
(worst)–100 (best)
Possible range: 0 
(best)–3 (worst)
Possible range: 0 
(best)–3 (worst)
Possible range: 0 
(best)–3 (worst)
Possible range: 0 
(best)–3 (worst)
Stable 65.9 (63.4–68.3) 0.82 (0.72–0.92) 1.29 (1.19–1.38) 1.12 (1.02–1.22) 1.08 (0.98–1.18)
Unstable 50.2 (48.8–51.6) 1.43 (1.36–1.51) 1.87 (1.81–1.93) 1.56 (1.49–1.63) 1.64 (1.57–1.71)
Deteriorating 42.9 (41.0–44.9) 1.23 (1.13–1.33) 1.92 (1.83–2.00) 1.53 (1.44–1.62) 1.78 (1.69–1.87)
Dying 16.6 (15.3–17.8) 0.94 (0.77–1.11) 1.62 (1.45–1.79) 0.97 (0.81–1.14) 1.61 (1.47–1.77)
a Difference in mean function by Phase of Illness statistically significant by one-way ANOVA (Welch’s F(3, 546.040) = 656.287, p < 0.001). Post hoc 
pairwise comparisons (Games Howell test) demonstrated statistically significant difference in the level of function for all pairwise comparisons 
(p < 0.05).
b Difference in mean pain by Phase of Illness statistically significant by one-way ANOVA (Welch’s F(3, 409.635) = 34.902, p < 0.001). Post hoc com-
parisons (Games Howell test) demonstrated statistically significant difference in all pairwise comparisons (p < 0.05) except between the stable and 
the dying phases (p = 0.619).
c Difference in mean other physical problems by Phase of Illness statistically significant by one-way ANOVA (Welch’s F(3, 390.481) = 39.930, 
p < 0.001). Post hoc comparisons (Games Howell test) demonstrated statistically significant difference in all pairwise comparisons (p < 0.05) except 
between the unstable and the deteriorating phases (p = 0.766).
d Difference in mean psycho-spiritual problems by Phase of Illness statistically significant by one-way ANOVA (Welch’s F(3, 403.815) = 28.356, 
p < 0.001). Post hoc pairwise comparisons (Games Howell test) demonstrated statistically significant difference in the level of psycho-spiritual 
problems for all pairwise comparisons (p < 0.05) except between the unstable and the deteriorating phases (p = 0.979) and the stable and the dying 
phases (p = 0.431).
e Difference in mean family and carer support needs by Phase of Illness statistically significant by one-way ANOVA (Welch’s F(3, 405.727) = 38.778, 
p < 0.001). Post hoc pairwise comparisons (Games Howell test) demonstrated statistically significant difference in family and carer support needs 
between the stable phase and all other phases (p < 0.05), but no other statistically significant differences (p < 0.05).
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was discriminated from all other phases by a higher level of 
pain. A lower level of function distinguished the deteriorat-
ing phase from the stable and unstable phases, and the dying 
phase from all other phases. These results, while largely 
anticipated, illuminate the constructs used by healthcare pro-
viders when assigning Phase of Illness and serve to illustrate 
that Phase of Illness has clinically meaningful relationships 
with validated measures of function and problem severity.
Figure 1. Mean level of (a) function, (b) pain, (c) other physical problems, (d) psycho-spiritual problems and (e) family and carer 
support needs by Phase of Illness.
Reports are based on the analysis of available data: (a) 1305 phases, (b) 1261 phases, (c) 1260 phases, (d) 1259 phases and (e) 1259 phases (n = 1317). 
Figures within each bar denote mean value for corresponding Phase of Illness. Error bars denote 95% confidence interval around the mean.
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A number of findings deserve further consideration. 
While psycho-spiritual problems varied significantly with 
Phase of Illness in the univariate analysis, they were not 
associated with Phase of Illness in the multivariate analy-
sis. This may reflect the limitation of a 4-point scale to 
sufficiently discriminate between higher and lower levels 
of psycho-spiritual problems. The PCPSS has demon-
strated good inter-rater reliability but it is yet to undergo 
further validation.12 An alternate possibility, however, is 
that psycho-spiritual problems are addressed over longer 
time periods than a single phase, or may be less likely to 
trigger a change in care plan, and hence Phase of Illness. 
Psychological and emotional support has been incorpo-
rated within sets of quality indicators for palliative care 
and the possibility that such symptoms, of themselves, do 
not trigger a change in the plan of care and Phase of Illness, 
is of concern and requires further investigation.13,14
The finding that family and carer support needs were 
significantly greater in the deteriorating phase than the 
unstable phase in the multivariate analysis was of further 
interest. Pain (highest in the unstable phase) has been 
demonstrated to be positively associated with caregiver 
burden.15 The difference in family and carer support 
needs between the deteriorating and unstable phases 
reached significance after adjustment for pain alone. 
Reduced function, a feature of the deteriorating phase, 
has been associated with increased caregiver burden.16,17 
However, the increase in family and carer support needs 
in the deteriorating phase compared to the unstable 
phase retained significance after adjusting for reduced 
function suggesting there are other factors – in addition 
to reduced function – driving the higher family and carer 
support needs associated with the deteriorating phase. 
Of note, we did not explore the role of place of care as a 
driver of family and carer support needs. Place of care is 
conceivably associated with both Phase of Illness and 
family and carer support needs, and was not adjusted for 
in the analysis. Future studies should focus on under-
standing the role of place of care and other potential fac-
tors in mediating increased family and carer support 
needs in the deteriorating phase.
Finally, it is of interest that the combination of PCPSS 
and AKPS did not fully account for the variation in Phase 
of Illness (accounting for 49% by Nagelkerke’s pseudo 
R2). In making the determination of Phase of Illness, this 
suggests that healthcare providers are taking considera-
tions beyond the combination of AKPS and PCPSS into 
account. In this sense, Phase of Illness can be considered 
to capture clinical information in addition to the combina-
tion of these instruments. We examined only the relation-
ship between the absolute values on the PCPSS, AKPS and 
Phase of Illness. It is conceivable that change in these 
dimensions is a greater determinant of Phase of Illness 
than absolute values.
Strengths and limitations
Understanding the relationship between Phase of Illness 
and existing validated measures of need in palliative care 
is important and valuable. Phase of Illness already forms 
the basis of the casemix classification in operation in 
Australia as well as the newly developed casemix classifi-
cation for specialist palliative care within England, which 
is currently undergoing evaluation.2,18 A considerable 
strength of the study was the successful use of routinely 
collected individual patient-level data to answer the 
research question, an approach that is both economical and 
facilitates research on a large sample.19 The analysis of 
data from a large number of patients, with a range of diag-
noses, in a variety of settings, serves furthermore to 
enhance the generalisability of the study’s findings.
The study’s limitations merit further consideration. 
First, while the use of routinely collected data has its 
strengths (described above), there are also a number of 
limitations, specifically constraints in terms of the range of 
variables measured, the consistency and quality of data 
recording, and the instruments used. In particular, pain, 
other physical problems, psycho-spiritual problems and 
family and carer support needs were all measured using 
the PCPSS. While this measure is yet to undergo formal 
validation, it has good inter-rater reliability and has 
been used extensively in the Palliative Care Outcomes 
Table 4. Multinomial logistic regression of Phase of Illness (dependent variable) using function, pain, other physical problems, 
psycho-spiritual problems and family and carer support needs as independent variables, based on analysis of 1252 admission phases 
– unstable phase as the reference phase.
Function Pain Other physical 
problems
Psycho-spiritual 
problems
Family and carer 
support needs
Unstable
Stable vs 1.44 (1.30–1.59) 0.51 (0.41–0.63) 0.57 (0.45–0.73) 0.87 (0.68–1.11) 0.68 (0.54–0.85)
Deteriorating vs 0.81 (0.75–0.88) 0.77 (0.66–0.90) 1.03 (0.85–1.26) 0.94 (0.77–1.14) 1.23 (1.01–1.49)
Dying vs 0.13 (0.08–0.19) 0.73 (0.53–0.99) 1.10 (0.77–1.57) 0.78 (0.55–1.11) 1.16 (0.83–1.61)
Data are based on the analysis of 1252 complete cases due to missing data on 65 cases. Model χ2 = 741.034, df = 15, p < 0.005; Pearson’s χ2 = 1516.796, 
df = 1779, p = 1.000; Nagelkerke’s pseudo R2 = 0.488. Numbers indicate odds ratios (95% confidence intervals in brackets) for the association between 
the reference phase (italics) and the corresponding comparison phase.
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Collaborative, a national initiative in Australia to collate 
and compare patient-centred outcomes among palliative 
care services.3,12 However, the four 4-point subscales may 
be limited in scope or sensitivity to capture the full range 
of problems experienced by this population, which could 
account for some of the unexplained variation in Phase of 
Illness in the multivariate analysis. Other instruments, 
such as the Palliative care Outcome Scale or the Edmonton 
Symptom Assessment Scale, could be considered in the 
collection of patient-reported outcomes.20 A further limita-
tion of this study is the risk of sampling bias. The study 
sample is broadly representative of patients receiving pal-
liative care based on gender, age and diagnosis; however, 
lack of data on individuals not included and reasons for 
exclusion limits our evaluation of sample bias.21 Future 
studies relying on the use of routinely collected data would 
be strengthened by characterisation of all eligible individ-
uals within the service over the time period of analysis, 
independent of their inclusion in the final sample.
Conclusion
This study, to our knowledge, is the first to examine the 
association between Phase of Illness and validated meas-
ures of palliative care need, including function, pain, other 
physical problems, psycho-spiritual problems and family 
and carer support needs. The findings are of great impor-
tance in providing an understanding of the metrics used by 
healthcare providers to inform Phase of Illness and in char-
acterising the nature of the different phases. Furthermore, 
they provide necessary and timely evidence to support the 
use of Phase of Illness as a measure of need within pallia-
tive care.
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